Anti-LOX 1 antibody [EPR20750]
- RabMAb
- Recombinant
- 20ul selling size
- What is this?
Be the first to review this product! Submit a review
|
(11 Publications)
Rabbit Recombinant Monoclonal LOX 1 antibody. Suitable for WB and reacts with Human, Mouse, Rat samples. Cited in 11 publications.
View Alternative Names
CLEC8A, LOX1, OLR1, Oxidized low-density lipoprotein receptor 1, Ox-LDL receptor 1, C-type lectin domain family 8 member A, Lectin-like oxidized LDL receptor 1, Lectin-type oxidized LDL receptor 1, LOX-1, Lectin-like oxLDL receptor 1, hLOX-1
- WB
Unknown
Western blot - Anti-LOX 1 antibody [EPR20750] (AB214427)
All lanes:
Western blot - Anti-LOX 1 antibody [EPR20750] (ab214427) at 1/1000 dilution
Lane 1:
Human fetal vessel lysate at 20 µg
Lane 2:
Mouse placenta lysate at 20 µg
Lane 3:
Rat placenta lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>)
Predicted band size: 31 kDa
Observed band size: 52 kDa
false
- WB
Supplier Data
Western blot - Anti-LOX 1 antibody [EPR20750] (AB214427)
Blocking/Dilution buffer : 5% NFDM/TBST.
The expression profile is consistent with what has been described in the literature (PMID : 10692464, PMID : 15016631).
All lanes:
Western blot - Anti-LOX 1 antibody [EPR20750] (ab214427) at 1/1000 dilution
Lane 1:
Untreated THP-1 (human monocytic leukemia cell line) whole cell lysate at 20 µg
Lane 2:
THP-1 treated with 100 ng/ml phorbol-12-myristate-13-acetate (PMA) for 72 hours, whole cell lysate at 20 µg
Lane 3:
Untreated HUVEC (human umbilical vein endothelial cell line) whole cell lysate at 20 µg
Lane 4:
HUVEC treated with 100 ng/ml phorbol-12-myristate-13-acetate (PMA) for 8 hours, whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 31 kDa
Observed band size: 52 kDa
false
Exposure time: 3min
Related conjugates and formulations (1)
-
Anti-LOX 1 antibody [EPR20750] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (11)
Recent publications for all applications. Explore the full list and refine your search
Genes & diseases 12:101761 PubMed40837406
2025
Applications
Unspecified application
Species
Unspecified reactive species
Endokrynologia Polska 76:116-123 PubMed40071808
2025
Applications
Unspecified application
Species
Unspecified reactive species
Food science & nutrition 12:8000-8012 PubMed39479713
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in neuroscience 18:1442110 PubMed39234183
2024
Applications
Unspecified application
Species
Unspecified reactive species
Annals of translational medicine 11:42 PubMed36819529
2023
Applications
Unspecified application
Species
Unspecified reactive species
Annals of translational medicine 10:700 PubMed35845495
2022
Applications
Unspecified application
Species
Unspecified reactive species
Bioengineered 13:13872-13881 PubMed35707830
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 25: PubMed35293601
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 13:4 PubMed34921134
2021
Applications
Unspecified application
Species
Unspecified reactive species
BioMed research international 2021:9983725 PubMed34471643
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com